| Primary |
| Nephrogenic Anaemia |
42.1% |
| Hypertension |
14.6% |
| Drug Use For Unknown Indication |
7.3% |
| Prophylaxis |
6.1% |
| Glomerulonephritis Chronic |
5.3% |
| Product Used For Unknown Indication |
4.8% |
| Diabetic Nephropathy |
4.2% |
| Nephrosclerosis |
2.0% |
| Anaemia |
1.9% |
| Hyperparathyroidism |
1.6% |
| Renal Failure Chronic |
1.5% |
| Immunosuppression |
1.3% |
| Microscopic Polyangiitis |
1.1% |
| Diabetes Mellitus |
1.0% |
| Dialysis |
1.0% |
| Hypothyroidism |
0.9% |
| Gastritis |
0.8% |
| Hypertensive Nephropathy |
0.8% |
| Renal Failure |
0.8% |
| Coronary Artery Disease |
0.7% |
|
| Death |
22.1% |
| Haemoglobin Decreased |
9.1% |
| Pneumonia |
7.7% |
| Sepsis |
7.2% |
| Renal Impairment |
5.8% |
| Pulmonary Embolism |
5.5% |
| Hypertension |
4.7% |
| Pyrexia |
4.4% |
| Renal Failure Chronic |
3.6% |
| Peripheral Arterial Occlusive Disease |
3.3% |
| Renal Failure |
3.3% |
| Sudden Death |
3.0% |
| Anaemia |
2.8% |
| Cerebrovascular Accident |
2.8% |
| Urinary Tract Infection |
2.8% |
| Gastrointestinal Haemorrhage |
2.5% |
| Platelet Count Decreased |
2.5% |
| Thrombosis |
2.5% |
| Atrial Fibrillation |
2.2% |
| Cardiac Failure |
2.2% |
|
| Secondary |
| Nephrogenic Anaemia |
42.3% |
| Hypertension |
14.6% |
| Prophylaxis |
5.7% |
| Diabetic Nephropathy |
5.6% |
| Product Used For Unknown Indication |
4.4% |
| Renal Failure |
2.9% |
| Tuberculosis |
2.9% |
| Renal Failure Chronic |
2.8% |
| Drug Use For Unknown Indication |
2.5% |
| Atrial Fibrillation |
2.4% |
| Hyperphosphataemia |
2.4% |
| Glomerulonephritis Chronic |
1.7% |
| Microscopic Polyangiitis |
1.6% |
| Gastritis |
1.5% |
| Hyperparathyroidism Secondary |
1.5% |
| Mineral Supplementation |
1.2% |
| Secondary Hyperthyroidism |
1.2% |
| Vitamin D Deficiency |
1.2% |
| Diabetes Mellitus |
0.9% |
| Rheumatoid Arthritis |
0.7% |
|
| Spinal Osteoarthritis |
10.0% |
| Myocarditis |
9.4% |
| Death |
9.1% |
| Haemoglobin Decreased |
8.5% |
| Post Procedural Haemorrhage |
6.3% |
| Peripheral Arterial Occlusive Disease |
5.7% |
| Tuberculous Pleurisy |
5.1% |
| Anaemia |
4.3% |
| Upper Gastrointestinal Haemorrhage |
4.3% |
| Sepsis |
4.0% |
| Cerebral Infarction |
3.7% |
| Renal Failure Chronic |
3.7% |
| Bile Duct Cancer |
3.4% |
| Hypotension |
3.4% |
| Intestinal Ischaemia |
3.4% |
| Refractory Anaemia |
3.4% |
| Shunt Thrombosis |
3.4% |
| Hypertension |
3.1% |
| Peritonitis |
2.8% |
| Pulmonary Oedema |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.0% |
| Rheumatoid Arthritis |
15.9% |
| Multiple Myeloma |
9.5% |
| Prophylaxis |
6.3% |
| Bacterial Pyelonephritis |
4.8% |
| Juvenile Idiopathic Arthritis |
4.8% |
| Anaemia |
3.2% |
| Atrial Fibrillation |
3.2% |
| Blood Potassium |
3.2% |
| Gastrooesophageal Reflux Disease |
3.2% |
| Hyperparathyroidism Secondary |
3.2% |
| Hypertension |
3.2% |
| Nephrogenic Anaemia |
3.2% |
| Neuropathy Peripheral |
3.2% |
| Osteolysis |
3.2% |
| Prophylaxis Against Transplant Rejection |
3.2% |
| Thrombosis Prophylaxis |
3.2% |
| Anaemia Prophylaxis |
1.6% |
| Cardiomyopathy |
1.6% |
| Diabetes Mellitus |
1.6% |
|
| Bone Pain |
7.1% |
| Cardio-respiratory Arrest |
7.1% |
| Convulsion |
7.1% |
| Dysarthria |
7.1% |
| Dyspnoea |
7.1% |
| Hyperuricaemia |
7.1% |
| Prothrombin Time Prolonged |
7.1% |
| Pupils Unequal |
7.1% |
| Rash Maculo-papular |
7.1% |
| Renal Failure Chronic |
7.1% |
| Renal Impairment |
7.1% |
| Tachypnoea |
7.1% |
| Tremor |
7.1% |
| Viral Infection |
7.1% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
| Platelet Count Decreased |
96.3% |
| Rhabdomyolysis |
3.7% |
|
